Crossject Société Anonyme (EPA:ALCJ) Is About To Turn The Corner

Crossject Société Anonyme (EPA:ALCJ) is possibly approaching a major achievement in its business, so we would like to shine some light on the company. Crossject Société Anonyme develops needle-free injection systems in France. The €111m market-cap company’s loss lessened since it announced a €13m loss in the full financial year, compared to the latest trailing-twelve-month loss of €11m, as it approaches breakeven. Many investors are wondering about the rate at which Crossject Société Anonyme will turn a profit, with the big question being “when will the company breakeven?” Below we will provide a high-level summary of the industry analysts’ expectations for the company.

This technology could replace computers: discover the 20 stocks are working to make quantum computing a reality.

According to some industry analysts covering Crossject Société Anonyme, breakeven is near. They expect the company to post a final loss in 2024, before turning a profit of €24m in 2025. So, the company is predicted to breakeven approximately 12 months from now or less. At what rate will the company have to grow in order to realise the consensus estimates forecasting breakeven in under 12 months? Using a line of best fit, we calculated an average annual growth rate of 65%, which signals high confidence from analysts. If this rate turns out to be too aggressive, the company may become profitable much later than analysts predict.

We're not going to go through company-specific developments for Crossject Société Anonyme given that this is a high-level summary, however, keep in mind that by and large a high growth rate is not out of the ordinary, particularly when a company is in a period of investment.

View our latest analysis for Crossject Société Anonyme

Before we wrap up, there’s one issue worth mentioning. Crossject Société Anonyme currently has negative equity on its balance sheet. This can sometimes arise from accounting methods used to deal with accumulated losses from prior years, which are viewed as liabilities carried forward until it cancels out in the future. Oftentimes, losses exist only on paper but other times, it can be a red flag.

Next Steps:

There are key fundamentals of Crossject Société Anonyme which are not covered in this article, but we must stress again that this is merely a basic overview. For a more comprehensive look at Crossject Société Anonyme, take a look at Crossject Société Anonyme's company page on Simply Wall St. We've also compiled a list of pertinent factors you should look at:

1. Valuation: What is Crossject Société Anonyme worth today? Has the future growth potential already been factored into the price? The intrinsic value infographic in our free research report helps visualize whether Crossject Société Anonyme is currently mispriced by the market.
2. Management Team: An experienced management team on the helm increases our confidence in the business – take a look at who sits on Crossject Société Anonyme’s board and the CEO’s background.
3. Other High-Performing Stocks: Are there other stocks that provide better prospects with proven track records? Explore our free list of these great stocks here.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.